Special Issue

Topic: Treatment of Pancreatic Cancer

A Special Issue of Journal of Cancer Metastasis and Treatment

ISSN 2454-2857 (Online) 2394-4722 (Print)

Submission deadline: 30 Apr 2022

Guest Editor(s)

Prof. Marco Falasca
School of Pharmacy and Biomedical Sciences, Faculty of Health Sciences, Curtin University, Perth, Australia.

Special Issue Introduction

Pancreatic cancer is an increasingly common malignancy that has benefited very little from research advancements and new discoveries, as it remains largely an untreatable disease with a 5-year survival rate lower than 9%.  The reasons for this setback are searched in the lack of specific early-stage symptomatology, leading to a late diagnosis and consequently limited option of treatment, as well as resistance to chemo- and radiotherapy and high metastatic potential. Disruption of cell signaling pathways and genetic alterations involving activation of oncogenes and blocking of tumor suppressors are well known to contribute to the start and progression of this tumor. Yet, new understanding and insight, particularly guiding towards new strategies for improved therapies, is eagerly awaited. This Special Issue intends to publish original research, expert opinions, and reviews on basic, translational and clinical studies connected to different aspects of pancreatic cancer cell biology, genomics, precision medicine, medical oncology, radiation therapy, and surgery.

Keywords

Pancreatic Cancer

Submission Deadline

30 Apr 2022

Submission Information

For Author Instructions, please refer to https://www.oaepublish.com/jcmt/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=jcmt&SpecialIssueId=876
Submission Deadline: 30 Apr 2022
Contacts: Carl Zhou, Assistant Editor, Carl.Zhou@jcmtjournal.com

Published Articles

Recent advances in detecting premalignant pancreatic cysts

Open Access Review DOI: 10.20517/2394-4722.2022.122 14 Apr 2023
Views: Downloads:
Download PDF

Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?

Open Access Review DOI: 10.20517/2394-4722.2022.106 6 Mar 2023
Views: Downloads:
Download PDF

More efficient clinical trials in pancreatic cancer: develop better treatment options, faster

Open Access Opinion DOI: 10.20517/2394-4722.2022.58 18 Oct 2022
Views: Downloads:
Download PDF

Neoadjuvant treatment of pancreatic ductal adenocarcinoma: present and future

Open Access Review DOI: 10.20517/2394-4722.2022.43 17 Sep 2022
Views: Downloads:
Download PDF

A shifting adversary: control of pancreatic cancer transcriptomic subtypes

Open Access Review DOI: 10.20517/2394-4722.2022.71 21 Aug 2022
Views: Downloads:
Download PDF

The role of systemic therapy in borderline resectable and locally advanced pancreatic ductal adenocarcinoma

Open Access Review DOI: 10.20517/2394-4722.2022.48 14 Aug 2022
Views: Downloads:
Download PDF

Utility of circulating tumor DNA for predicting prognosis in the management of resectable pancreatic cancer

Open Access Review DOI: 10.20517/2394-4722.2022.20 28 Jul 2022
Views: Downloads:
Download PDF
Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/